<DOC>
	<DOCNO>NCT00002219</DOCNO>
	<brief_summary>The purpose study see safe effective give adefovir ( new anti-HIV drug ) plus nelfinavir HIV-infected child already receive anti-HIV medication .</brief_summary>
	<brief_title>Safety Effectiveness Adding Adefovir Dipivoxil Nelfinavir Anti-HIV Therapy HIV-Infected Children</brief_title>
	<detailed_description>During first phase study ( Days 1-6 ) , safety tolerability multiple dos ADF assess administer simultaneously patient 's reverse transcriptase inhibitor ( RTI ) regimen . The second phase begin Day 7 nelfinavir add therapy regimen additional 15 week . ADF pharmacokinetics measure Days 1 , 2 , 7 ( subset 18 patient ) ; peak trough sample collect Day 28 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Inclusion Criteria Your child may eligible study he/she : Is 3 month 16 year old . Is HIVpositive . Has never take protease inhibitor previously take ritonavir ( RTV ) , saquinavir ( SQV ) , indinavir ( IDV ) willing stop medication study entry . Is take antiHIV drug combination change least 2 week prior study entry . Agrees use effective barrier method birth control , condom , study . Has consent parent guardian . Exclusion Criteria Your child eligible study he/she : Has ever take NFV . Has history opportunistic ( AIDSrelated ) infection . Has disease illness would prevent him/her complete study , include cancer . Has take certain medication , include protease inhibitor study entry . Is receive HIV vaccine study entry . Is pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Disease Progression</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Adenine</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Age Factors</keyword>
	<keyword>Nelfinavir</keyword>
</DOC>